{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:50:34Z","timestamp":1792050634489,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.euf.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:43:25Z","timestamp":1537782205000},"page":"42-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Role of Human Papilloma Virus in Penile Cancer Prevention and New Therapeutic Agents"],"prefix":"10.1016","volume":"5","author":[{"given":"Boris","family":"Schlenker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schneede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2018.09.010_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.euf.2018.09.010_bib0010","first-page":"449","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.euf.2018.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/modpathol.2009.77","article-title":"HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis","volume":"22","author":"Stankiewicz","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euf.2018.09.010_bib0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.euf.2018.09.010_bib0025","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","year":"2016"},{"issue":"Suppl 3","key":"10.1016\/j.euf.2018.09.010_bib0030","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.euf.2018.09.010_bib0035","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ypmed.2011.08.002","article-title":"Genital HPV infection and related lesions in men","volume":"53","author":"Anic","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.euf.2018.09.010_bib0040","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4161\/hv.29137","article-title":"HPV vaccination in boys and men","volume":"10","author":"Stanley","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.euf.2018.09.010_bib0045","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1017\/S0950268817000747","article-title":"Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence","volume":"145","author":"Signorelli","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.euf.2018.09.010_bib0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268815002198","article-title":"Prophylactic HPV vaccination: past, present, and future","volume":"144","author":"Castle","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.euf.2018.09.010_bib0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2018.09.010_bib0060","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.euf.2018.09.010_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2018.09.010_bib0070","first-page":"255","article-title":"RKI-Ratgeber Humane Papillomviren","volume":"27","author":"Robert Koch-Institut","year":"2018","journal-title":"Epidemiologisches Bulletin"},{"key":"10.1016\/j.euf.2018.09.010_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","article-title":"History of circumcision, medical conditions, and sexual activity and risk of penile cancer","volume":"85","author":"Maden","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2018.09.010_bib0080","first-page":"267","article-title":"Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States)","volume":"12","author":"Tsen","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.euf.2018.09.010_bib0085","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ijc.21009","article-title":"Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease","volume":"116","author":"Daling","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2018.09.010_bib0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1677-55382011000200010","article-title":"Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases","volume":"37","author":"Koifman","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euf.2018.09.010_bib0095","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/14760584.2016.1176533","article-title":"Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies","volume":"15","author":"Vici","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.euf.2018.09.010_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1586\/14760584.2016.1157477","article-title":"Current state in the development of candidate therapeutic HPV vaccines","volume":"15","author":"Yang","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.euf.2018.09.010_bib0105","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/hum.2014.024","article-title":"Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine","volume":"25","author":"Rosales","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.euf.2018.09.010_bib0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ygyno.2018.01.009","article-title":"Cervical cancer \u2013 State of the science: From angiogenesis blockade to checkpoint inhibition","volume":"148","author":"Minion","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.euf.2018.09.010_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2741\/e808","article-title":"Therapeutic strategies for human papillomavirus infection and associated cancers","volume":"10","author":"Bharti","year":"2018","journal-title":"Front Biosci (Elite Ed)"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456918302827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456918302827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:47:48Z","timestamp":1762498068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456918302827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2405456918302827"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2018.09.010","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Human Papilloma Virus in Penile Cancer Prevention and New Therapeutic Agents","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}